4.6 Article

Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement Meta-Analysis of Kaplan-Meier-Derived Individual Patient Data

Journal

JACC-CARDIOVASCULAR IMAGING
Volume 16, Issue 3, Pages 298-310

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcmg.2022.07.013

Keywords

cardiac surgical procedures; cardiovascular surgical procedures; heart valve diseases; heart valve prosthesis implantation; meta-analysis; transcatheter aortic valve replacement

Ask authors/readers for more resources

This study evaluated the time-varying effects and association of prosthesis-patient mismatch (PPM) with the risk of overall mortality following transcatheter aortic valve replacement (TAVR). The results showed that severe PPM was significantly associated with higher mortality risk after TAVR, while moderate PPM did not show a significant correlation with mortality. These findings support the implementation of preventive strategies to avoid severe PPM.
BACKGROUND It remains controversial whether prosthesis-patient mismatch (PPM) (in general considered moderate if indexed effective orifice area is 0.65-0.85 cm(2)/m(2) and severe when <0.65 cm(2)/m(2)) affects the outcomes after transcatheter aortic valve replacement (TAVR). OBJECTIVES The purpose of this study is to evaluate the time-varying effects and association of PPM with the risk of overall mortality. METHODS Study-level meta-analysis of reconstructed time-to-event data from Kaplan-Meier curves of studies published by December 30, 2021. RESULTS In total, 23 studies met our eligibility criteria and included a total of 81,969 patients included in the Kaplan-Meier curves (19,612 with PPM and 62,357 without PPM). Patients with moderate/severe PPM had a significantly higher risk of mortality compared with those without PPM (HR: 1.09 [95% CI: 1.04-1.14]; P < 0.001). In the first 30 months after the procedure, mortality rates were significantly higher in the moderate/severe PPM group (HR: 1.1 [95% CI: 1.05-1.16]; P < 0.001). In contrast, the landmark analysis beyond 30 months yielded a reversal of the HR (0.83 [95% CI: 0.68-1.01]; P = 0.064), but without statistical significance. In the sensitivity analysis, although the authors observed that severe PPM showed higher risk of mortality in comparison with no PPM (HR: 1.25 [95% CI: 1.16-1.36]; P < 0.001), they did not observe a statistically significant difference for mortality between moderate PPM and no PPM (HR: 1.03 [95% CI: 0.96-1.10]; P = 0.398). CONCLUSIONS Severe PPM, but not moderate PPM, was associated with higher risk of mortality following TAVR. These results provide support to implementation of preventive strategies to avoid severe PPM following TAVR. (c) 2023 by the American College of Cardiology Foundation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available